Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2178]

ASCO 2023: Targeted therapy achieves responses across multiple cancer types with FGFR alterations

ASCO 2023: Targeted therapy achieves responses across multiple cancer types with FGFR alterations

ASCO 2023: Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location

ASCO 2023: Trastuzumab deruxtecan effectively treats HER2-expressing cancers regardless of tumour location

Personalising prostate cancer screening may improve the accuracy of detection

Personalising prostate cancer screening may improve the accuracy of detection

NCCN joins collaboration to improve standards in cancer care for vietnam

NCCN joins collaboration to improve standards in cancer care for vietnam

FDA approves olaparib with abiraterone and prednisone (or prednisolone) for BRCA-mutated mCRPC

FDA approves olaparib with abiraterone and prednisone (or prednisolone) for BRCA-mutated mCRPC

ASCO 2023: Extended lymph node removal does not benefit patients with clinically localised muscle-invasive bladder cancer

ASCO 2023: Extended lymph node removal does not benefit patients with clinically localised muscle-invasive bladder...

Cancer survivors who quit smoking have 36% lower cardiovascular risk than continuers

Cancer survivors who quit smoking have 36% lower cardiovascular risk than continuers

FDA approves blue earth diagnostics’ flotufolastat F 18 injection, first radiohybrid PSMA-targeted PET imaging agent for prostate cancer

FDA approves blue earth diagnostics’ flotufolastat F 18 injection, first radiohybrid PSMA-targeted PET imaging...

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

Prostate cancer ‘test by request’ policies drive overdiagnosis and inequity with minimal benefit

Prostate cancer ‘test by request’ policies drive overdiagnosis and inequity with minimal benefit

More from ecancer